Emcure Pharmaceuticals Ltd Financial Flexibility Index
Emcure Pharmaceuticals Ltd financial flexibility index. Emcure Pharmaceuticals Ltd (EMCURE) has a Financial Flexibility Index of 0.09x as of September 2025. Free cash flow of Rs3.85 Billion (operating CF Rs2.56 Billion minus capex Rs1.29 Billion) represents 0% of total liabilities (Rs45.09 Billion). Explore Emcure Pharmaceuticals Ltd capital spending ratio to see what proportion of operating cash flow is directed to capital expenditures.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Emcure Pharmaceuticals Ltd (2022–2026)
Financial flexibility index of Emcure Pharmaceuticals Ltd from 2022 to 2026. Historical Financial Flexibility Index trend for Emcure Pharmaceuticals Ltd across 5 annual periods. Check EMCURE total capital reinvestment ratio to assess the company's total reinvestment commitment from operating cash flow.
Emcure Pharmaceuticals Ltd Financial Flexibility Index by Year (2022–2026)
Emcure Pharmaceuticals Ltd financial flexibility index by year from 2022 to 2026. Year-by-year free cash flow to debt coverage for Emcure Pharmaceuticals Ltd. For the full cash flow conversion analysis, see EMCURE cash flow metrics.
| Year | Flexibility Index | Free Cash Flow (INR) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2026 | 0.26x | Rs12.11 Billion | Rs8.51 Billion | Rs46.36 Billion | ▼ -25.5% |
| 2025 | 0.35x | Rs12.59 Billion | Rs8.52 Billion | Rs35.91 Billion | ▲ +16.9% |
| 2024 | 0.30x | Rs14.04 Billion | Rs10.97 Billion | Rs46.84 Billion | ▲ +4.9% |
| 2023 | 0.29x | Rs11.50 Billion | Rs7.47 Billion | Rs40.23 Billion | ▼ -3.1% |
| 2022 | 0.30x | Rs11.65 Billion | Rs7.68 Billion | Rs39.49 Billion | — |